Progress of recurrence of venous thromboembolism in cancer patients
10.3760/cma.j.issn.1006-9801.2018.06.018
- VernacularTitle:肿瘤患者静脉血栓栓塞复发的研究进展
- Author:
Chengjie WANG
1
;
Hualiang REN
;
Biao YUAN
;
Chunmin LI
Author Information
1. 100020,北京朝阳医院血管外科
- Keywords:
Venous thromboembolism;
Recurrence;
Low molecular weight heparins;
Anticoagulants
- From:
Cancer Research and Clinic
2018;30(6):426-429
- CountryChina
- Language:Chinese
-
Abstract:
Cancer patients complicated with venous thromboembolism (VTE) face treatment problems, very high recurrence rate and bleeding rate. Cancer itself and the antitumor treatment plan are the important factors causing the recurrence. After the relapse, the prognosis of the patients is extremely bad, and more than 50% of the patients died within 1 year. Until now, there is no unified effective treatment plan for the relapse. This paper reviews the recurrence of VTE and the related research progress.